GBIO — Generation Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00- $24.13m
- -$133.43m
- $19.89m
- 32
- 64
- 37
- 41
Annual cashflow statement for Generation Bio Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -80.5 | -119 | -137 | -127 | -132 |
| Depreciation | |||||
| Non-Cash Items | 8.66 | 18.6 | 28 | 15.1 | 69.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.71 | 4.17 | 1.05 | 53.5 | -31.4 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -70.1 | -91.8 | -102 | -52.7 | -88.6 |
| Capital Expenditures | -5.52 | -5.96 | -8.8 | -7.4 | -2.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -200 | 199 | -184 | -2.3 | 96.9 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -205 | 193 | -193 | -9.7 | 94.5 |
| Financing Cash Flow Items | -3.23 | -0.955 | -0.631 | -0.729 | -0.186 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 323 | 215 | 13 | 35.8 | 0.25 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 47.8 | 316 | -282 | -26.6 | 6.22 |